Researchers have identified underlying KRAS mutations which drive associated risk of particular clinical outcomes. Researchers at Weill Cornell Medicine, New York-Presbyterian and Memorial Sloan ...

The success of CAR-Ts in oncology has stoked enthusiasm for developing comparable curative therapies in other disease areas. CellProthera’s Chief Scientific Officer, Ibon Garitaonandia, explains the ...

Researchers at the University of California San Diego have discovered two distinct molecular subtypes of Crohn’s disease by studying organoids derived from adult stem cells in the intestine tissue ...

Results from Pistoia Alliance’s Lab of the Future survey has shared important findings about the challenges life science companies face. The results from The Pistoia Alliance’s Lab of the Future ...

Results from Pistoia Alliance’s Lab of the Future survey has shared important findings about the challenges life science companies face.

In this in-depth Q&A, Mutlu Dogruel, Vice President of AI at Cresset shares his insights surrounding chatbots, retrieval augmented generation and AI hallucinations, to open up new possibilities for ...

This study is the first to demonstrate that NSD2 is foundational to the earliest stage of prostate cancer development. Scientists at the University of Michigan Health Rogel Cancer Center have ...

Cincinnati Children’s have repaired damaged intestines in a rodent model, moving research efforts closer to clinical trials. Cincinnati Children’s have made a significant achievement in organoid ...

Scientists have developed a monoclonal antibody drug that could help to prevent infection from Acinetobacter baumannii. University of Cambridge scientists have led the development of a monoclonal ...